Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib tablets | Tech Reddy
[ad_1] Glenmark Pharmaceuticals Inc., USA (Glenmark) and Glenmark Pharmaceuticals Limited have reached an agreement with Pfizer Inc., PF Prism CV and PF Prism IMB BV (Pfizer) for their generic version of Axitinib tablets, 1 mg and 5 mg. Inlyta®1 tablets, 1 mg and 5 mg. Glenmark announced on November 30, 2020 that it has received … Read more